No Data
Buy Rating Affirmed for Compass Therapeutics on Strong Financials and Promising Clinical Trials
Asia And Europe Markets Mixed, Gold Hovers Around $2,350 - Global Markets Today While US Slept
Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
BOSTON, May 14, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics t
Express News | Compass Inc : Deutsche Bank Raises Target Price to $4 From $3.8
Elite Learning Introduces New Guide for Nursing Career Paths in 2024 Career Compass
Elite Learning, a comprehensive online learning destination for licensed professionals, today announced the introduction of the 2024 Nursing Career Compass, a practical guide for popular nursing career paths. "The
Express News | Compass Therapeutics Inc. : Leerink Partners Cuts Target Price to $10 From $11